Plus, news about RheumaGen and RyboDyn:
Numab Therapeutics brings in $55M: The Swiss biotech extended its Series C, originally disclosed in ...
↧
Channel:
Endpoints News
X
Are you the publisher?
Claim or
contact us
about this channel.
X
No ratings yet.
Channel Details:
- Title: Endpoints News
- Channel Number: 80426484
- Language: English
- Registered On: May 17, 2024, 12:59 pm
- Number of Articles: 3020
- Latest Snapshot: April 12, 2025, 3:59 am
- RSS URL: https://endpts.com/biogen-and-ionis-abandon-als-drug-after-disappointing-early-stage-trial/feed/
- Publisher: https://endpts.com/
- Description: Biotech and pharma business news, with a focus on the science, people and money that drive the...
- Catalog: //endpoints1651.rssing.com/catalog.php?indx=80426484
© 2025 //www.rssing.com